Medical/Pharmaceuticals

I-Mab Presents Positive Uliledlimab Pharmacokinetics Data at 2024 World Conference on Lung Cancer

- Pharmacokinetic/pharmacodynamic (PK/PD) modeling data from three Phase 1 studies providing dosing support for upcoming clinical trials - Exposure-Response (E-R) Analysis showed a positive correlation between uliledlimab concentration and ORR probability in mNSCLC patients - Randomized Phase 2 st...

2024-09-10 19:00 933

Updated Data from Phase II Clinical Trial of Iruplinalkib Tablets (Qixinke®) Presented at World Conference on Lung Cancer 2024

JINAN, China, Sept. 10, 2024 /PRNewswire/ -- During the World Conference on Lung Cancer (WCLC) held fromSeptember 7-10, 2024, in San Diego, California, updated findings from the Phase II clinical trial (INTELLECT study) were presented. The study assessed the efficacy and safety of Qilu Pharmaceut...

2024-09-10 18:00 975

The 2024 International (Bozhou) TCM Expo Kicked Off

BOZHOU, China, Sept. 10, 2024 /PRNewswire/ -- On the morning of September 9, the 2024 International (Bozhou) TCM Expo and the 40th National (Bozhou) TCM Trade Fair officially kicked off in Bozhou,Anhui Province. In recent years, Bozhou has been enhancing mechanisms for the inheritance, innovatio...

2024-09-10 17:55 861

RingConn Showcases Gen 2 Smart Ring at IFA 2024: Revolutionizing Sleep Monitoring with Integrated Sleep Apnea Detection

BERLIN, Sept. 10, 2024 /PRNewswire/ -- RingConn , a leading personal health technology company, recently showcased its newest innovation—the RingConn Gen 2 Smart Ring—at IFA 2024. This groundbreaking device is the first smart ring to feature integrated sleep ...

2024-09-10 15:00 1328

ICP DAS-BMP Reveals Advanced Engineering TPUs at Medtec China 2024

HSINCHU, Sept. 10, 2024 /PRNewswire/ -- ICP DAS-BMP (Biomedical Polymers), a Taiwan-based medical TPU (thermoplastic polyurethane) manufacturer and supplier, is excited to announce its participation in Medtec China 2024. The 18th edition of this exhibition will be held fromSeptember 25-27, 202...

2024-09-10 09:30 1593

Innovent Delivers Oral Presentation of Updated Results from a Pivotal Phase 2 Study of Dupert® (Fulzerasib) in Patients with Advanced Non-Small Cell Lung Cancer Harboring KRAS G12C Mutation

SAN FRANCISCO and SUZHOU, China, Sept. 10, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmun...

2024-09-10 08:00 1865

IonOpticks partners with Adelis to accelerate global expansion and innovation

IonOpticks responds to growing global market needs for proteomics tools by partnering with Nordic private equity firm MELBOURNE, Australia and STOCKHOLM, Sept. 10, 2024 /PRNewswire/ -- IonOpticks , a leading global producer of high-performance chromatography columns, ann...

2024-09-10 06:00 1550

Seegene Expands mpox RUO Product Lineups with Enhanced Detection Assays for Clade 1

* Introduces Novaplex™ MPXV/OPXV plus Assay (RUO) that is designed to detect Clade I, which has higher transmission and mortality rates than Clade II * Adheres to the WHO issued target product profiles and provides accurate detection of viral strains * Offers healthcare professionals with ...

2024-09-09 22:15 1946

Bambusa Therapeutics Inc. Announces Successful Series Seed Funding to Advance Innovative Bispecific Antibodies for Immunology & Inflammation

BOSTON, Sept. 9, 2024 /PRNewswire/ -- Bambusa Therapeutics Inc., a biotechnology company focused on developing bispecific antibodies for the treatment of immunological and inflammatory (I&I) disorders, announced the successful closing of its Series Seed financing round, raising approximately$15 ...

2024-09-09 21:09 1112

Lunit Joins Roche's Digital Pathology Open Environment to Advance Cancer Biomarker Testing

* Lunit's AI-powered biomarker, Lunit SCOPE PD-L1 TPS, integrates into Roche's navify® Digital Pathology platform to enhance precision medicine and improve cancer biomarker testing SEOUL, South Korea, Sept. 9, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solution...

2024-09-09 21:00 1339

Neurophet-NTU Singapore, recognized for outstanding joint research

- Neurophet accelerates global expansion for research and partnership in AI-driven brain image analysis SEOUL, South Korea, Sept. 9, 2024 /PRNewswire/ -- Neurophet, an artificial intelligence (AI) solution company for brain disease, announced that Neurophet and NTU (Nanyang Technological Univers...

2024-09-09 21:00 1445

GenAssist Ltd Announced the First DMD Patient Dosed with its Base Editing Drug

SUZHOU, China, Sept. 9, 2024 /PRNewswire/ -- On September 06, 2024, GenAssist Ltd (GenAssist), announced the first DMD patient dosed with its base editing drug, GEN6050X injection, in an investigator-initiated trial (IIT). "This is the first-in-human trial for DMD gene editing therapy. It marks t...

2024-09-09 21:00 1157

Frost & Sullivan grants the Global Targeted Molecular Fluorescent Tracer R&D Leadership Award to Nanjing Nuoyuan Medical Devices Co., Ltd.

SHANGHAI, Sept. 9, 2024 /PRNewswire/ -- Frost & Sullivan is pleased to announce that the 18th Growth Innovation Leadership (GIL) Summit and the 3rd New Investment Event (NIE 2024), was held inShanghai from August 27 to 30, 2024, co-hosted by LeadLeo. Based on research and analysis of the global ...

2024-09-09 20:06 1271

Frost & Sullivan grants the Global Biologics CDMO Technology Leadership Award to BiBo Pharma

SHANGHAI, Sept. 9, 2024 /PRNewswire/ -- Frost & Sullivan is pleased to announce that the 18th Growth Innovation Leadership (GIL) Summit and the 3rd New Investment Event (NIE 2024), was held inShanghai from August 27 to 30, 2024, co-hosted by LeadLeo. Based on research and analysis of the global ...

2024-09-09 19:51 1435

Sirsram Medical announces NMPA approval for DAXXIFY®

Marking the introduction of the world's first and only peptide-powered  botulinum toxin product to Mainland China HONG KONG, Sept. 9, 2024 /PRNewswire/ -- Sisram Medical (1696.HK), a global leading innovator and provider of holistic medical aesthetic solutions announced today that the National M...

2024-09-09 19:46 1353

Intelligent Technology Empowers the Future of Rehabilitation: Siyi Intelligence (Syrebo) Shines at WRRC 2024

i-CREATe & WRRC 2024 SHANGHAI, Sept. 9, 2024 /PRNewswire/ -- Siyi Intelligence (Syrebo) played a prominent role at the International Convention on Rehabilitation Engineering and Assistive Technology (i-CREATe 2024) & the World Rehabilitation Robot Convention 2024 (WRRC 2024), held inShanghai fro...

2024-09-09 17:41 1485

MGI Launches New Nanopore Sequencing Products with Advanced CycloneSEQ Technology

SHENZHEN, China, Sept. 9, 2024 /PRNewswire/ -- MGI Tech Co., Ltd. ("MGI"), a company committed to building core tools and technologies that drive innovation in life science, today announced the global rights to commercialize and distribute the new sequencing products CycloneSEQ-WT02* and CycloneS...

2024-09-09 16:24 1185

A. Menarini Diagnostics and Nucleix announce a strategic partnership for a non-invasive bladder cancer test in Europe

Under the commercial agreement, A. Menarini Diagnostics will assume exclusive marketing of the non-invasive Bladder EpiCheck® test in Europe in the months ahead, providing patients and clinicians with a urine test to detect and monitor recurrence of bladder cancer and upper tract urothelial carci...

2024-09-09 15:00 1078

Formosa Pharmaceuticals Makes First Shipment of APP13007 (Clobetasol Propionate Ophthalmic Suspension, 0.05%) to the United States for Commercialization

TAIPEI, Sept. 9, 2024 /PRNewswire/ -- Formosa Pharmaceuticals, Inc. (hereinafter referred to as "Formosa Pharma," 6838.TW) announced the successful first shipment tothe United States of its new ophthalmic drug, Clobetasol Propionate Ophthalmic Suspension, 0.05% (APP13007), manufactured by Bora P...

2024-09-09 15:00 1061

Australia Urged to Lead Global Effort Against Childhood Dementia

CANBERRA, Australia, Sept. 9 2024 /PRNewswire/ -- A groundbreaking new report, "State of Childhood Dementia inAustralia 2024," released today at Australia's Parliament House inCanberra by the Childhood Dementia Initiative, has revealed the devastating impact of childhood dementia on Australian fa...

2024-09-09 15:00 1237
1 ... 27282930313233 ... 610